FORM 8.3 - AON PLC

FORM 8.3 - AON PLC

BARCLAYS PLC

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 18 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

432,641

0.19%

2,132,695

0.93%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

418,023

0.18%

30,257

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

23,000

0.01%

23,000

0.01%

 

 

 

 

(4)

TOTAL:

 

 

 

 

873,664

0.38%

2,185,952

0.96%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

6

227.4800 USD
Purchase

13

227.7100 USD
Purchase

14

228.0728 USD
Purchase

25

228.6980 USD
Purchase

44

226.9550 USD
Purchase

46

226.4800 USD
Purchase

100

227.3200 USD
Purchase

133

227.5878 USD
Purchase

180

229.0600 USD
Purchase

196

227.3651 USD
Purchase

206

228.6647 USD
Purchase

214

226.8094 USD
Purchase

215

228.9472 USD
Purchase

263

227.4614 USD
Purchase

304

228.4864 USD
Purchase

315

227.8369 USD
Purchase

365

226.9160 USD
Purchase

500

228.4143 USD
Purchase

522

228.2424 USD
Purchase

600

228.5241 USD
Purchase

600

228.3616 USD
Purchase

605

228.2700 USD
Purchase

627

227.8608 USD
Purchase

640

227.6059 USD
Purchase

1,300

228.1988 USD
Purchase

1,618

228.0100 USD
Purchase

1,830

227.3245 USD
Purchase

3,365

227.7691 USD
Purchase

3,795

228.3051 USD
Purchase

4,051

227.2600 USD
Purchase

6,500

227.2053 USD
Purchase

9,091

227.8031 USD
Purchase

9,923

227.5858 USD
Purchase

13,508

227.0293 USD
Purchase

14,219

227.7023 USD
Purchase

15,814

227.1684 USD
Purchase

17,683

227.6968 USD
Purchase

77,050

227.8602 USD
Purchase

127,656

227.7883 USD
Sale

4

227.1200 USD
Sale

50

227.1500 USD
Sale

100

226.8400 USD
Sale

155

226.8448 USD
Sale

180

229.0600 USD
Sale

200

226.9650 USD
Sale

200

228.7200 USD
Sale

205

227.8181 USD
Sale

300

228.1700 USD
Sale

300

228.2106 USD
Sale

307

228.2475 USD
Sale

500

227.7750 USD
Sale

501

226.9818 USD
Sale

505

227.7070 USD
Sale

601

227.3646 USD
Sale

650

227.0753 USD
Sale

763

227.5055 USD
Sale

800

227.4956 USD
Sale

813

227.1186 USD
Sale

874

227.0694 USD
Sale

1,223

227.9594 USD
Sale

1,597

227.3437 USD
Sale

1,618

228.0100 USD
Sale

1,750

227.0950 USD
Sale

1,757

228.4815 USD
Sale

1,891

227.6179 USD
Sale

1,933

228.3252 USD
Sale

2,510

227.0427 USD
Sale

3,541

228.0836 USD
Sale

3,927

227.5386 USD
Sale

3,960

227.6860 USD
Sale

4,151

227.7837 USD
Sale

4,431

227.2600 USD
Sale

4,498

227.2713 USD
Sale

5,138

228.4038 USD
Sale

5,905

226.9940 USD
Sale

7,765

227.6073 USD
Sale

7,973

227.7835 USD
Sale

12,462

227.5924 USD
Sale

13,634

227.7068 USD
Sale

20,057

227.1654 USD
Sale

33,622

227.5487 USD
Sale

77,215

227.8577 USD
Sale

84,005

227.8908 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 19 Feb 2021
Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date

 

to which the option

 

 

 

 

or derivative

 

 

 

 

relates

 

 

 

Call Options

Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings